Skip to main content
. 2020 May 25;9:100199. doi: 10.1016/j.pvr.2020.100199

Table 2.

Prevalence of different HPV Genotypes with Linear Assay and SPF10 PCR-DEIA-LiPA25 System within the Oral HIM Sub-cohort that Underwent Both Tests.

HPV Genotypea Linear Array
N (%)
SPF10 PCR-DEIA-LiPA25 System
N (%)
SPF10 PCR-DEIA-LiPA25 System/Linear Array
Prevalence Ratio
6 3 (0.21) 13 (0.90) 4.3
11 2 (0.14) 3 (0.21) 1.5
16 7 (0.48) 26 (1.82) 3.7
18 0 (0.00) 4 (0.28) N/A
31 0 (0.00) 4 (0.28) N/A
33 0 (0.00) 1 (0.07) N/A
35 1 (0.07) 4 (0.28) 4.0
39 1 (0.07) 7 (0.48) 7.0
40 0 (0.00) 0 (0.00) N/A
42 0 (0.00) 0 (0.00) N/A
45 0 (0.00) 2 (0.14) N/A
51 3 (0.21) 13 (0.90) 4.3
52 1 (0.07) 7 (0.48) 7.0
53 1 (0.07) 9 (0.62) 9.0
54 0 (0.00) 2 (0.14) N/A
56 0 (0.00) 8 (0.55) N/A
58 1 (0.07) 3 (0.21) 3.0
59 2 (0.14) 2 (0.14) 1.0
66 4 (0.27) 12 (0.83) 3.0
68 0 (0.00) 1 (0.07) N/A
70 2 (0.14) 1 (0.07) 0.5
Any HPV genotype 28 (1.92) 126 (8.66) 4.5
Any High-Risk HPV 16 (1.1) 76 (5.22) 4.8
Any Low-Risk HPV 12 (0.82) 53 (3.64) 4.4
HPV type 6 and/or 11 and/or 16 and/or 18 12 (0.82) 46 (3.16) 3.8
HPV type 6 and/or 11 and/or 16 and/or 18 and/or 31 and/or 33 and/or 45 and/or 52 and/or 58 14 (0.96) 61 (4.19) 4.4
a

Total sample size for all HPV types: 1455.